Showing results (51-60 of 116) with videos related to
Sort By:
Pageof 12
Journal of the American Society for Mass Spectrometry|January 27, 2023
Matrix Development for the Detection of Phosphorylated Amyloid-β Peptides by MALDI-TOF-MSThomas Liepold, Hans-Wolfgang Klafki, Sathish Kumar, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|May 6, 2009
Circulating immune complexes of Abeta and IgM in plasma of patients with Alzheimer's diseaseAndrea Marcello, Oliver Wirths, Thomas Schneider-Axmann, et al.Neurobiology of Aging|December 25, 2012
Abundant pyroglutamate-modified ABri and ADan peptides in extracellular and vascular amyloid deposits in familial British and Danish dementiasAnika Saul, Tammaryn Lashley, Tamas Revesz, et al.Journal of Chemical Neuroanatomy|March 30, 2010
Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic miceWolfgang Härtig, Simone Goldhammer, Ute Bauer, et al.Cell Communication and Signaling : CCS|April 26, 2025
N-terminal truncation of STAT1 transcription factor causes CD3- and CD20-negative non-Hodgkin lymphoma through upregulation of STAT3-mediated oncogenic functionsSana Mumtaz Sheikh, Julia Staab, Martina Bleyer, et al.Neurobiology of Aging|September 29, 2009
Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's diseaseAndrea Marcello, Oliver Wirths, Thomas Schneider-Axmann, et al.Acta Neuropathologica|November 1, 2008
Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI miceDitte Zerlang Christensen, Sophie Luise Kraus, Antonius Flohr, et al.Acta Neuropathologica Communications|October 21, 2018
Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microgliaMelanie Hüttenrauch, Isabella Ogorek, Hans Klafki, et al.Fluids and Barriers of the CNS|December 2, 2022
Is plasma amyloid-β 1-42/1-40 a better biomarker for Alzheimer's disease than AβX-42/X-40?Hans-Wolfgang Klafki, Barbara Morgado, Oliver Wirths, et al.BMC Molecular and Cell Biology|June 25, 2022
Evaluation of the putative lymphoma-associated point mutation D427H in the STAT3 transcription factorLena Sophie Behrendsen, Priyanka Rajeev Menon, Muhammad Jawad Khan, et al.Pageof 12